Literature DB >> 8268465

Cytosolic PLA2: mRNA levels and potential for transcriptional regulation.

J D Sharp1, D L White.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8268465

Source DB:  PubMed          Journal:  J Lipid Mediat        ISSN： 0921-8319


× No keyword cloud information.
  12 in total

Review 1.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

2.  Study on the relationship of cPLA2, CK-MB, and membrane phospholipid content in acute myocardial infarction.

Authors:  Li Wei-hua; Han Jun-yu; Sun Chang-qing; Guo Yong-jun; Xie Qiang; Lin Kai-min; Wu Rong; Zhao Yan; Lin Lin
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

3.  Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.

Authors:  Xiao-Xia Fang; Xiao-Lin Jiang; Xin-Hua Han; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Cell Mol Neurobiol       Date:  2012-11-16       Impact factor: 5.046

Review 4.  Regulation and metabolism of arachidonic acid.

Authors:  M C Seeds; D A Bass
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

5.  In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection.

Authors:  G Nardone; E L Holicky; J R Uhl; L Sabatino; S Staibano; A Rocco; V Colantuoni; B A Manzo; M Romano; G Budillon; F R Cockerill; L J Miller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 6.  Phospholipase A2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques.

Authors:  L J De Windt; R S Reneman; G J Van der Vusse; M Van Bilsen
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

7.  Expression of phospholipases A2 and C in human corneal epithelial cells.

Authors:  Solange Landreville; Stéphanie Coulombe; Patrick Carrier; Michael H Gelb; Sylvain L Guérin; Christian Salesse
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-11       Impact factor: 4.799

Review 8.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

9.  A novel phospholipase A2 from human placenta.

Authors:  W J Buhl; L M Eisenlohr; I Preuss; U Gehring
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

10.  Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2014-08-27       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.